; Whereas the physical pain of women of color is routinely dismissed by medical professionals and society as a whole, contributing to their pain and the cascading effects therefrom; Whereas studies have shown that racial bias can affect how doctors assess and treat pain, including a 2016 study that showed trainees who believed that Black people are not as sensitive to pain as White people were less likely to treat Black people’s pain appropriately; Whereas migraine disease is three times more common in women, reaching peak prevalence between 30 and 39 years of age, at a time when many women are rapidly growing in their career and balancing work, family, and social obligations, further contributing to the wage gap; Whereas women account for a large majority of the estimated $78,000,000,000 in migraine-associated economic costs in the United States, representing about 80 percent of both direct medical costs and lost labor costs including presenteeism and absenteeism; Whereas migraine disease has significant negative consequences for individuals, their families, and society as a whole; Whereas the National Institutes for Health (NIH) funded less than $40,000,000 in headache disorders research in fiscal year 2019, amounting to 0.1 percent of the total NIH budget, and comparisons with NIH funding of other diseases of similar disability and disease burden indicate that funding of headache disorders research should instead exceed $200,000,000 each year; Whereas migraine disease and cluster headache are disabling diseases but largely symptomatic, without reliable diagnostic physical signs or lab findings, meaning that Federal regulations prohibiting claimant symptoms from supporting SSDI/SSI eligibility as medically determinable impairments in sequential evaluation unfairly prevent their inclusion; and Whereas access to relief from cluster headache is often inexplicably limited by lack of insurance and Medicare coverage of safe and effective oxygen therapy: Now, therefore, be it